Aadi Bioscience, Inc.AADINASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank92
3Y CAGR+44.4%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
+44.4%/yr
vs -17.1%/yr prior
Acceleration
+61.5pp
Accelerating
Percentile
P92
Near historical high
vs 3Y Ago
3x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 70.96% |
| Q2 2025 | -346.37% |
| Q1 2025 | 21.19% |
| Q4 2024 | 4.04% |
| Q3 2024 | -71.31% |
| Q2 2024 | 53.41% |
| Q1 2024 | -103.78% |
| Q4 2023 | 19.30% |
| Q3 2023 | 28.68% |
| Q2 2023 | 21.36% |
| Q1 2023 | -88.42% |
| Q4 2022 | -38.01% |
| Q3 2022 | 23.55% |
| Q2 2022 | 44.78% |
| Q1 2022 | -56.22% |
| Q4 2021 | 28.46% |
| Q3 2021 | -445.46% |
| Q2 2021 | -130.15% |
| Q1 2021 | 422.53% |
| Q4 2020 | -7.94% |
| Q3 2020 | -57.85% |
| Q2 2020 | 56.99% |
| Q1 2020 | 8.13% |
| Q4 2019 | -2.14% |
| Q3 2019 | 7.44% |
| Q2 2019 | 43.31% |
| Q1 2019 | -46.78% |
| Q4 2018 | 0.60% |
| Q3 2018 | -147.45% |
| Q2 2018 | 301.30% |
| Q1 2018 | -41.22% |
| Q4 2017 | -14.77% |
| Q3 2017 | 36.44% |
| Q2 2017 | -60.92% |
| Q1 2017 | -102622.12% |
| Q4 2016 | 69.26% |
| Q3 2016 | -100.32% |
| Q2 2016 | 199.79% |
| Q1 2016 | -141203.43% |
| Q4 2015 | 28.34% |